First Header Logo Second Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Shapiro, Michael
Item TypeName
Concept Cholesterol, HDL
Concept Cholesterol, LDL
Concept Cholesterol
Academic Article Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
Academic Article US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry.
Academic Article Targeting PCSK9 for therapeutic gains.
Academic Article Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab.
Academic Article Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy.
Academic Article The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.
Academic Article Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.
Academic Article Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9.
Academic Article Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiology.
Academic Article Translating AHA/ACC cholesterol guidelines into meaningful risk reduction.
Academic Article PCSK9: From Basic Science Discoveries to Clinical Trials.
Academic Article Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.
Academic Article PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy.
Academic Article "Cholesterol-Years" for ASCVD Risk Prediction and Treatment.
Academic Article Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry.
Academic Article Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies.
Search Criteria
  • Cholesterol